Emergent Biosolutions EBS Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 54.2%-1.9pp | 56.1%+1.6pp | 54.5%+1.0pp | 53.5%+18.3pp | 35.2%+0.5pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×-0.1× | 0.5×0.0× | 0.5×0.0× | 0.6×0.0× | 0.6×-0.1× | |
| Liquidity | ||||||
| Current ratio | 4.3×-0.7× | 5×-0.8× | 5.8×+0.1× | 5.7×-0.7× | 6.3×+2.6× | |
| Leverage | ||||||
| Debt-to-equity | 1.1×0.0× | 1.1×0.0× | 1.2×-0.1× | 1.3×0.0× | 1.2×-0.2× | |
| Per Share | ||||||
| Book value per share | $9.26+0.5% | $9.22-10.6% | $10.31+4.2% | $9.89+2.6% | $9.65+5.9% | |
| Valuation | ||||||
| Market capitalization | $411.74M+22.0% | $649.15M+38.0% | $470.56M+28.1% | $367.46M+39.1% | $264.08M-49.0% | |
| Price / sales | 0.6×+0.3× | 0.9×+0.3× | 0.6×+0.2× | 0.4×+0.2× | 0.3×-0.2× | |
| Price / book | 0.8×+0.2× | 1.2×+0.4× | 0.8×+0.1× | 0.7×+0.2× | 0.5×-0.6× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Emergent Biosolutions's profit margins?
- Emergent Biosolutions (EBS) runs a 54.2% gross margin and a 15.0% operating margin, with a 9.6% net margin.
- Where do Emergent Biosolutions's ratios come from?
- Every ratio is computed from Emergent Biosolutions's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
